Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
NovoBiome is a French biotechnology company focused on developing breakthrough therapies for liver and intestinal diseases by targeting the microbiome-gut-liver axis. The company specializes in the discovery and development of Live Biotherapeutic Products (LBPs) - a novel class of drugs containing living microorganisms that positively influence host health and physiology. NovoBiome is building a disruptive, ex-vivo research and discovery platform called NovoSift®. This platform mimics human intestinal physiology and enables detailed analysis of the symbiotic relationship between the microbiota and the human intestine
Source: Company information
…